Literature DB >> 25540922

Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.

Ilias C Papanikolaou1, Kyriaki A Boki2, Evangelos J Giamarellos-Bourboulis3, Antigoni Kotsaki4, Konstantinos Kagouridis5, Napoleon Karagiannidis6, Vlasis S Polychronopoulos7.   

Abstract

BACKGROUND: This is a prospective cohort study elucidating innate immunity in idiopathic pulmonary fibrosis (IPF), cryptogenic organizing pneumonia (COP), rheumatoid arthritis-associated usual interstitial pneumonia (RA-UIP) and RA-associated non specific interstitial pneumonia (RA-NSIP).
METHODS: 23 IPF subjects, 9 COP subjects, 5 RA-UIP subjects, 8 RA-NSIP subjects were enrolled. 10 subjects were excluded. 19 healthy subjects served as controls. Blood and bronchoalveolar lavage (BAL) were obtained. Natural killer (NK) and NKT cells, NK cells apoptosis and the expression of triggering receptor expressed on myeloid cells type 1 (TREM-1) were assessed. Tumor necrosis factor-α (TNF-α) production was measured in cell cultures after stimulation with lipopolysaccharide endotoxin (LPS) and Pam3CysSK3, and in BAL. Surface expression of Toll-like receptors (TLR) 2 and 4 on peripheral blood monocytes (PBMC's) and circulating NK cells was also assessed.
RESULTS: RA-NSIP had low blood NKs, marginally insignificant (p=0.07). These NKs poorly produced TNF-α after LPS stimulation. TLR's expression on NK cells was similar throughout disease groups and controls. PBMC's mainly from IPF patients exhibited low TNF-α production after LPS stimulation but not after Pam3CysSK3 stimulation, while TLR4 expression on PBMC's was found normal in all study groups. TLR2 expression on PBMC's was increased in IPF, but mainly in COP, RA-UIP and RA-NSIP (p=0.015). TREM-1 expression was significant on COP monocytes and on COP neutrophils versus controls. RA-NSIP monocytes also exhibited TREM-1 expression (p=0.07). Decreased TNF-α concentration in BAL was finally observed in IPF and RA-UIP.
CONCLUSIONS: Innate immunity in the lungs and the peripheral circulation in IPF and RA-UIP are similar and more fibrotic than in RA-NSIP which is characterized by NK cell depletion and dysfunction. TREM-1 and TLR's likely affect patterns of inflammation in various interstitial lung diseases.
Copyright © 2014 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Innate immunity; Interstitial lung diseases; Natural killer cells; Rheumatoid arthritis; Toll-like receptors; Triggering receptor expressed on myeloid cells 1

Mesh:

Substances:

Year:  2014        PMID: 25540922     DOI: 10.1016/j.imlet.2014.12.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

1.  NK and NKT-like cells in granulomatous and fibrotic lung diseases.

Authors:  L Bergantini; P Cameli; M d'Alessandro; C Vagaggini; R M Refini; C Landi; M G Pieroni; M Spalletti; P Sestini; E Bargagli
Journal:  Clin Exp Med       Date:  2019-09-04       Impact factor: 3.984

2.  Pre-exposure to Aerosolized Polyvalent Bacterial Lysates Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice.

Authors:  Xiaoling Zhu; Shan Yuan; Xiaofang Zheng; Xiaorong Wang; Jinnong Zhang
Journal:  Inflammation       Date:  2022-03-05       Impact factor: 4.092

Review 3.  The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease.

Authors:  David N O'Dwyer; Robert P Dickson; Bethany B Moore
Journal:  J Immunol       Date:  2016-06-15       Impact factor: 5.422

4.  Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria.

Authors:  John H Hwang; Matthew Lyes; Katherine Sladewski; Shymaa Enany; Elisa McEachern; Denzil P Mathew; Soumita Das; Alexander Moshensky; Sagar Bapat; David T Pride; Weg M Ongkeko; Laura E Crotty Alexander
Journal:  J Mol Med (Berl)       Date:  2016-01-25       Impact factor: 4.599

5.  Modeling using clinical examination indicators predicts interstitial lung disease among patients with rheumatoid arthritis.

Authors:  Yao Wang; Wuqi Song; Jing Wu; Zhangming Li; Fengyun Mu; Yang Li; He Huang; Wenliang Zhu; Fengmin Zhang
Journal:  PeerJ       Date:  2017-02-21       Impact factor: 2.984

6.  Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia.

Authors:  A Manfredi; F Luppi; G Cassone; C Vacchi; C Salvarani; M Sebastiani
Journal:  Expert Rev Clin Immunol       Date:  2020-10-03       Impact factor: 4.473

7.  Soluble ST2 in serum predicts the prognosis of idiopathic pulmonary fibrosis: a retrospective study.

Authors:  Yan-Zhe Yu; Xian-Hua Gui; Min Yu; Wen Huang; Li-Yao Peng; Jing-Hong Dai; Qing-Qing Xu; Ting-Ting Zhao; Wei-Ping Xie; Yong-Long Xiao; Ping Yuan; Yan Li
Journal:  Ann Transl Med       Date:  2022-07

Review 8.  Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis.

Authors:  Tanyalak Parimon; Miriam S Hohmann; Changfu Yao
Journal:  Int J Mol Sci       Date:  2021-06-09       Impact factor: 5.923

Review 9.  Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations.

Authors:  Tihong Shao; Xiaodong Shi; Shanpeng Yang; Wei Zhang; Xiaohu Li; Jingwei Shu; Shehabaldin Alqalyoobi; Amir A Zeki; Patrick S Leung; Zongwen Shuai
Journal:  Front Immunol       Date:  2021-06-07       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.